S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Puma Biotechnology Announces Positive Top Line Results from PB272 Phase II Trial in HER2 Positive Metastatic Breast Cancer (NEfERTT Trial)|
|Puma Biotechnology Announces Positive Interim PB272 (Neratinib) Phase II Data at 2014 CTRC-AACR San Antonio Breast Cancer Symposium|
|Puma Biotechnology Reports Third Quarter 2014 Financial Results|
|Puma Biotechnology to Present at Stifel 2014 Healthcare Conference|
|Puma Biotechnology Updates Timeline for Filing New Drug Application|
|Puma Biotechnology Announces Positive Initial Results from PB272 Phase II Trial in HER2 Mutated Non-Small Cell Lung Cancer|
|SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Puma Biotechnology, Inc.|
|Puma Biotech shares plummet on drug application delay|
|INVESTOR ALERT: Investigation of Puma Biotechnology, Inc. Announced by Glancy Binkow & Goldberg LLP|
|SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Puma Biotechnology, Inc. - PBYI|
Click above to view more mutual fund data and stats for pbyi - Puma Biotechnology Inc.